|
USP18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.324420E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.493600E-01 |
| Normal-vs-Stage2 |
2.930000E-01 |
| Normal-vs-Stage3 |
2.843800E-01 |
| Normal-vs-Stage4 |
9.93849999999519E-05 |
| Stage1-vs-Stage2 |
7.384600E-01 |
| Stage1-vs-Stage3 |
7.492000E-01 |
| Stage1-vs-Stage4 |
3.067700E-02 |
| Stage2-vs-Stage3 |
9.610000E-01 |
| Stage2-vs-Stage4 |
4.977900E-02 |
| Stage3-vs-Stage4 |
5.016200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.702160E-01 |
| Normal-vs-AfricanAmerican |
5.523600E-02 |
| Normal-vs-Asian |
9.417600E-01 |
| Caucasian-vs-AfricanAmerican |
4.208600E-01 |
| Caucasian-vs-Asian |
6.285600E-01 |
| AfricanAmerican-vs-Asian |
3.973600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.340800E-01 |
| Normal-vs-Female |
8.659800E-02 |
| Male-vs-Female |
3.845400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.447600E-04 |
| Normal-vs-Extreme_Weight |
1.247180E-01 |
| Normal-vs-Obese |
6.321600E-01 |
| Normal-vs-Extreme_Obese |
2.308200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.442100E-02 |
| Normal_Weight-vs-Obese |
8.497700E-03 |
| Normal_Weight-vs-Extreme_Obese |
7.551000E-01 |
| Extreme_Weight-vs-Obese |
4.107800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.110400E-01 |
| Obese-vs-Extreme_Obese |
2.826400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.410800E-01 |
| Normal-vs-Age(41-60Yrs) |
6.844400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.328000E-02 |
| Normal-vs-Age(81-100Yrs) |
7.064800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.670200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.975800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.092300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.050100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.386000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.612400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.072400E-01 |
| Normal-VS-Type2 PRCC |
2.711800E-02 |
| Normal-VS-KIRP CIMP |
2.618700E-03 |
| Normal-VS-Unclassified PRCC |
8.475600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.984200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
3.267600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.010800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.759600E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.916200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.240500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.984800E-01 |
| Normal-vs-N1 |
4.319000E-01 |
| Normal-vs-N2 |
2.477600E-03 |
| N0-vs-N1 |
7.905000E-01 |
| N0-vs-N2 |
9.592000E-02 |
| N1-vs-N2 |
2.337600E-01 |
|
|
